Health
HHS Allows Sale of Unapproved Peptides
The Department of Health and Human Services (HHS) has allowed compounding pharmacies to manufacture and sell unapproved peptides. This decision advances the Make America Healthy Again (MAHA) agenda but may raise concerns about regulatory oversight.
Coverage timeline — 1 article
The Hill
The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to the those championed by the Make America Healthy Again (MAHA) agenda. HHS stated in a notice that
2026-10-28 18:18 UTC